Literature DB >> 22531885

Revising the M235T polymorphism position for the AGT gene and reporting a modifying variant in the Brazilian population with potential cardiac and neural impact.

R R Lemos1, S G de Lima, J E Gomes da Cunha, D F Oliveira, M B Rodrigues de Souza, C F J Ayres, M F P M Albuquerque, J R M Oliveira.   

Abstract

There is a growing need to curate the overwhelming amount of sequencing data which is available in many public databases. For instance, new information shows that the M235T polymorphism at the angiotensinogen gene (AGT) is actually positioned at the position corresponding to the amino acid 268 and not 235. This polymorphism is filled as rs699 in the NCBI SNP database and results in the synthesis of a threonine (T) instead of a methionine (M). It has been widely studied and associated as an important risk factor for several vascular and neuropsychiatric conditions. We faced this new situation during the targeted sequencing of 360 chromosomes from Brazilian subjects studied for the M235T polymorphism, leading to the identification of a novel variation (rs141900991). This report explores the potential impact of such a dinucleotide variation, which promotes the change of alanine (A) to serine (S) at the AGT protein structure (A237S). Considering the previous M268T variation at the four possible haplotypes combined (MA, MS, TA and TS), we performed a comparative hydrophobicity simulation, using the Kyte-Doolittle algorithm, available at the CLB Bio workbench, in the four possible haplotypes. Additional simulations were performed using the programs PolyPhen, I-Mutant and SIFT, in order to evaluate the pathogenicity of both mutations. The predicted hydrophobicity decreases of a similar magnitude, with both MS and TA haplotypes, but the presence of both variations induces a major decrease in hydrophobicity, suggesting a cumulative effect, with possible modifying effect since that this variation per se would limit the hydrophobicity range and the latter chances in finding significant phenotype differences. A better characterization of this kind of variant is particularly important because the current genome wide scan analyses in complex disorders with cardiac or neural etiology are not generating reliable findings, especially if we consider the huge investment with such approach. Additional and unknown variations like this one, with potential modifying effect, might be more common than previously expected.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22531885     DOI: 10.1007/s12031-012-9768-7

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  13 in total

1.  Angiotensinogen and angiotensin converting enzyme gene polymorphisms and the risk of bipolar affective disorder in humans.

Authors:  I V Meira-Lima; A C Pereira; G F Mota; J E Krieger; H Vallada
Journal:  Neurosci Lett       Date:  2000-10-27       Impact factor: 3.046

2.  Genetic heterogeneity in human disease.

Authors:  Jon McClellan; Mary-Claire King
Journal:  Cell       Date:  2010-04-16       Impact factor: 41.582

3.  Major heart disease genes prove elusive.

Authors:  Jennifer Couzin-Frankel
Journal:  Science       Date:  2010-06-04       Impact factor: 47.728

4.  Renin angiotensin system polymorphisms in patients with metabolic syndrome (MetS).

Authors:  Lucia Maria Procopciuc; Adela Sitar-Tăut; Dana Pop; Dan-Andrei Sitar-Tăut; Ileana Olteanu; Dumitru Zdrenghea
Journal:  Eur J Intern Med       Date:  2010-07-01       Impact factor: 4.487

5.  Nucleotide diversity and haplotype structure of the human angiotensinogen gene in two populations.

Authors:  Toshiaki Nakajima; Lynn B Jorde; Tomoaki Ishigami; Satoshi Umemura; Mitsuru Emi; Jean-Marc Lalouel; Ituro Inoue
Journal:  Am J Hum Genet       Date:  2001-11-30       Impact factor: 11.025

6.  Left ventricular mass in relation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretion.

Authors:  Tatiana Kuznetsova; Jan A Staessen; Lutgarde Thijs; Christiane Kunath; Agnieszka Olszanecka; Andrew Ryabikov; Valérie Tikhonoff; Katarzyna Stolarz; Giuseppe Bianchi; Edoardo Casiglia; Robert Fagard; Stefan-Martin Brand-Herrmann; Kalina Kawecka-Jaszcz; Sofia Malyutina; Yuri Nikitin; Eva Brand
Journal:  Circulation       Date:  2004-10-18       Impact factor: 29.690

7.  Renin-angiotensin-aldosterone system in brain infarction and vascular death.

Authors:  David Brenner; Julien Labreuche; Odette Poirier; François Cambien; Pierre Amarenco
Journal:  Ann Neurol       Date:  2005-07       Impact factor: 10.422

8.  Dinucleotide polymorphism of p73 gene is associated with a reduced risk of lung cancer in a Chinese population.

Authors:  Zhibin Hu; Xiaoping Miao; Hongxia Ma; Wen Tan; Xinru Wang; Daru Lu; Qingyi Wei; Dongxin Lin; Hongbing Shen
Journal:  Int J Cancer       Date:  2005-04-10       Impact factor: 7.396

9.  Genotype-phenotype analysis of angiotensinogen polymorphisms and essential hypertension: the importance of haplotypes.

Authors:  W Scott Watkins; Steven C Hunt; Gordon H Williams; Whitney Tolpinrud; Xavier Jeunemaitre; Jean-Marc Lalouel; Lynn B Jorde
Journal:  J Hypertens       Date:  2010-01       Impact factor: 4.844

10.  AGT M235T genotype/anxiety interaction and gender in the HyperGEN study.

Authors:  Sarah S Knox; Xinxin Guo; Yuqing Zhang; G Weidner; Scott Williams; R Curtis Ellison
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

View more
  2 in total

1.  Neuromarkers of the common angiotensinogen polymorphism in healthy older adults: A comprehensive assessment of white matter integrity and cognition.

Authors:  Lauren E Salminen; Peter R Schofield; Kerrie D Pierce; Yi Zhao; Xi Luo; Youdan Wang; David H Laidlaw; Ryan P Cabeen; Thomas E Conturo; David F Tate; Erbil Akbudak; Elizabeth M Lane; Jodi M Heaps; Jacob D Bolzenius; Laurie M Baker; Lee M Cagle; Robert H Paul
Journal:  Behav Brain Res       Date:  2015-08-28       Impact factor: 3.332

2.  Limitations of the human reference genome for personalized genomics.

Authors:  Jeffrey A Rosenfeld; Christopher E Mason; Todd M Smith
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.